Discover
XRTX
XORTX Therapeutics Inc.
1.92
2 x 1.47
2 x 2.27
bid
ask
+
0.23
13.61%
2 @ 07:59 PM
1.87 -0.05 (2.60%)
| Ytd | -31.67% | |
| 1y | -55.35% |
1.74
day range
2.65
1.66
52 week range
5.50
| Open | 1.99 | Prev Close | 1.69 | Low | 1.74 | High | 2.65 | Mkt Cap | 3.49M |
| Vol | 7.22M | Avg Vol | 101.75K | EPS | -2.58 | P/E | N/A | Forward P/E | -0.67 |
| Beta | -0.21 | Short Ratio | 0.02 | Inst. Own | 6.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 2.11 | 200-d Avg | 2.36 | 1yr Est | 12.17 |
| Income Statement | |||
| Operating Expenses | 1.69M | ||
| Research and Development Expense | 113.93K | ||
| Selling, General and Administrative Expense | 1.43M | ||
| Operating Income | -1.69M | ||
| Net Income | -1.69M | ||
| Net Income Common Stock | -1.69M | ||
| Net Income Common Stock (USD) | -1.19M | ||
| Consolidated Income | -1.69M | ||
| Earnings per Basic Share | -1.05 | ||
| Earnings per Basic Share (USD) | -0.74 | ||
| Earnings per Diluted Share | -1.05 | ||
| Earning Before Interest & Taxes (EBIT) | -1.69M | ||
| Earning Before Interest & Taxes (USD) | -1.19M | ||
| Weighted Average Shares | 1.62M | ||
| Weighted Average Shares Diluted | 1.62M | ||
| Balance Sheet | |||
| Cash and Equivalents | 994.05K | ||
| Cash and Equivalents (USD) | 699.79K | ||
| Trade and Non-Trade Receivables | 88.09K | ||
| Current Assets | 2.44M | ||
| Total Assets | 6.18M | ||
| Current Liabilities | 679.52K | ||
| Total Liabilities | 679.52K | ||
| Accumulated Retained Earnings (Deficit) | -26.32M | ||
| Accumulated Other Comprehensive Income | -52.60K | ||
| Shareholders Equity | 5.50M | ||
| Shareholders Equity (USD) | 3.88M | ||
| Assets Non-Current | 3.75M | ||
| Goodwill and Intangible Assets | 2.55M | ||
| Trade and Non-Trade Payables | 678.52K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 18.32K | ||
| Net Cash Flow from Financing | 4.16M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 743.77K | ||
| Issuance (Purchase) of Equity Shares | 5.00M | ||
| Issuance (Repayment) of Debt Securities | -15.06K | ||
| Net Cash Flow from Investing | -139.46K | ||
| Net Cash Flow from Operations | -3.27M | ||
| Effect of Exchange Rate Changes on Cash | -6.41K | ||
| Share Based Compensation | 2.13K | ||